Zevra Therapeutics, Inc. (ZVRA)
12.39
-0.15
(-1.20%)
USD |
NASDAQ |
Sep 04, 16:00
12.39
0.00 (0.00%)
After-Hours: 20:00
Zevra Therapeutics Cash and Short Term Investments (Annual) : 191.01M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 191.01M |
| December 31, 2024 | 69.50M |
| December 31, 2023 | 43.05M |
| December 31, 2022 | 65.95M |
| December 31, 2021 | 112.35M |
| December 31, 2020 | 4.322M |
| December 31, 2019 | 3.217M |
| Date | Value |
|---|---|
| December 31, 2018 | 21.67M |
| December 31, 2017 | 43.33M |
| December 31, 2016 | 68.86M |
| December 31, 2015 | 51.32M |
| December 31, 2014 | 10.26M |
| December 31, 2013 | 1.969M |
| December 31, 2012 | 2.542M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Innoviva, Inc. | 566.67M |
| Collegium Pharmaceutical, Inc. | 406.53M |
| Johnson & Johnson | 20.10B |
| Ligand Pharmaceuticals, Inc. | 733.52M |
| Harrow, Inc. | 72.93M |